Page last updated: 2024-10-22

acetazolamide and T-Cell Lymphoma

acetazolamide has been researched along with T-Cell Lymphoma in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, RY1
Anderlini, P1
Naderi, AA1
Rivera, P1
Ahmadi, MA1
Esmaeli, B1

Other Studies

1 other study available for acetazolamide and T-Cell Lymphoma

ArticleYear
Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation.
    American journal of ophthalmology, 2002, Volume: 133, Issue:6

    Topics: Acetazolamide; Bone Marrow Transplantation; Brimonidine Tartrate; Choroid Diseases; Drug Therapy, Co

2002